Functional outcomes following chemoradiotherapy for head and neck cancer

被引:34
作者
Akst, LM
Chan, J
Elson, P
Saxton, J
Strome, M
Adelstein, D
机构
[1] Cleveland Clin Fdn, Dept Otolaryngol & Communicat Disorders, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Dept Biostat, Cleveland, OH 44195 USA
[3] Cleveland Clin Fdn, Dept Radiat Oncol, Cleveland, OH 44195 USA
[4] Cleveland Clin Fdn, Dept Hematol & Med Oncol, Cleveland, OH 44195 USA
关键词
D O I
10.1016/j.otohns.2004.05.020
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
OBJECTIVE: To study functional outcomes following concurrent chemoradiotherapy of head and neck cancer. METHODS. A retrospective chart review assessed diet, feeding tube use, and tracheotomy pretreatment and 3, 6, 12, and 24 months posttreatment. RESULTS. Of 196 patients who underwent chemoradiotherapy between 1990 and 2002, 148 (76%) required feeding tubes immediately posttreatment; 150 (77%) required nutritional support at 3 months. By 12 months, 92% were tube-free and 83% resumed near-normal diet. Of 17 patients (9%) with tracheotomy posttreatment, 71% were decannulated by 6 months. Stage IV disease strongly predicted prolonged feeding tube use and slow recovery of diet; age 60 also predicted slow recovery. Primary site, gender, and radiotherapy schedule did not predict functional recovery after adjusting for stage and age. CONCLUSION. Few patients required tracheotomy before or during chemoradiotherapy. Many patients required feeding tubes and nutritional support for several months following therapy, but most were tube-free and eating near-normal diets within 1 year.
引用
收藏
页码:950 / 957
页数:8
相关论文
共 26 条
[1]   Treatment of head and neck cancer: The role of chemotherapy [J].
Adelstein, DJ ;
Tan, EH ;
Lavertu, P .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1996, 24 (02) :97-116
[2]   Predictors of weight loss during radiation therapy [J].
Beaver, ME ;
Matheny, KE ;
Roberts, DB ;
Myers, JN .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2001, 125 (06) :645-648
[3]   Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer [J].
Buntzel, J ;
Kuttner, K ;
Frohlich, D ;
Glatzel, M .
ANNALS OF ONCOLOGY, 1998, 9 (05) :505-509
[4]   OVERVIEW OF COMBINED MODALITY THERAPIES FOR HEAD AND NECK-CANCER [J].
DIMERY, IW ;
HONG, WK .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (02) :95-111
[5]   Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer [J].
Eisbruch, A ;
Lyden, T ;
Bradford, CR ;
Dawson, LA ;
Haxer, MJ ;
Miller, AE ;
Teknos, TN ;
Chepeha, DB ;
Hogikyan, ND ;
Terrell, JE ;
Wolf, GT .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (01) :23-28
[6]   Swallow function in patients before and after intra-arterial chemoradiation [J].
Graner, DE ;
Foote, RL ;
Kasperbauer, JL ;
Stoeckel, RE ;
Okuno, SH ;
Olsen, KD ;
Sabri, AN ;
Maragos, NE ;
Cha, SS ;
Sargent, DJ ;
Strome, SE .
LARYNGOSCOPE, 2003, 113 (03) :573-579
[7]  
HIRSCH SM, 1991, LARYNGOSCOPE, V101, P583
[8]  
KOCH WM, 1995, ARCH OTOLARYNGOL, V121, P974
[9]   Aggressive concurrent chemoradiotherapy for squamous cell head and neck cancer -: An 8-year single-institution experience [J].
Lavertu, P ;
Adelstein, DJ ;
Saxton, JP ;
Secic, M ;
Eliachar, I ;
Strome, M ;
Larto, MA ;
Wood, BG .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1999, 125 (02) :142-148
[10]   Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy [J].
Lazarus, CL ;
Logemann, JA ;
Pauloski, BR ;
Colangelo, LA ;
Kahrilas, PJ ;
Mittal, BB ;
Pierce, M .
LARYNGOSCOPE, 1996, 106 (09) :1157-1166